Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease (Q44265033)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

hypercholesterolemia

0 references

0 references

Christie M. Ballantyne

3

object named as

Christie M Ballantyne

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Dennis W Schneck

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Robert H Knopp

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ruth McPherson

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rohini R Chitra

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Steven G Simonson

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

33-41

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

The Eating Pattern Assessment Tool: a simple instrument for assessing dietary fat and cholesterol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Prospective evaluation of a stiff shaft glide wire compared with the standard straight wire in crossing severely stenotic aortic valves

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Drug treatment of lipid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902994-6

7 January 2021

Identifiers

10.1016/S0002-9149(02)02994-6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44265033&oldid=2108994458"